TerrAscend (TSNDF) Net Income Growth (3y) (2024 - 2026)
TerrAscend (TSNDF) Net Income Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 51.28% |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | 2.94% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -62.58% |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn | 4.50% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | -7.75% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 66.11% |
| 9 | Elanco Animal Health | 12.60 Bn | 12.18 Bn | 785.00 Mn | -17.90% |
| 10 | TerrAscend | 168.49 Mn | 168.02 Mn | 34.60 Mn | 31.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.09% |
| Dec 31, 2025 | 33.68% |
| Sep 30, 2025 | -12.01% |
| Jun 30, 2025 | -149.13% |
| Mar 31, 2025 | -26.84% |
| Dec 31, 2024 | -168.24% |
| Sep 30, 2024 | -28.06% |
| Jun 30, 2024 | 26.03% |
| Mar 31, 2024 | -1.72% |